3 Top Biotech Stocks to Buy for the Long Haul

3 Top Biotech Stocks to Buy for the Long Haul

The United Nations anticipates that the global population over the age of 65 is expected to surge from 727 million people in 2020 to over 1.5 billion people by 2050. Long-term investors should consider purchasing Amgen (NASDAQ: AMGN). There are 20 molecules currently in phase 1 clinical trials and 19 molecules in phase 2 or 3 clinical trials.